$43MSeries B, 13 November 2025
Funds commercialization of Clairity Breast, Breast 3D and the upcoming Clairity Heart tool.
- Amount
- $43M
- Stage
- Series B
- Announced
- 13 November 2025
- Lead
- Ace Global Equity
- Other investors
- Sante Ventures, Breast Cancer Research Foundation
- Use of funds
- Funds commercialization of Clairity Breast, Breast 3D and the upcoming Clairity Heart tool.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Pred builtinboston.com
Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Pred news.google.com